Digitalization of Clinical Research: Nordic area moving forward

Thursday, May 23rd, 2019 - Copenhagen

Official language: English
Download the brochure

Digitalization of Clinical Research: Nordic area moving forward

The drug development process as we know it is being transformed through digitalisation.

Increased computing power is allowing new insights through data mining, simulation and artificial intelligence.

Work processes that so far have been handled by humans are starting to be automated, e.g. through robotics processes. All done to minimise cost in the drug development process in form of time and ressources.

While the shorter-term benefits of digitalisation are gradually becoming tangible, there are also longer-term aspirations to transform the entire operating model of clinical research. Consortia like TransCelerate Biopharma, Clinical Trials Transformation Initiative (CTTI) and Innovative Medicines Initiative (IMI) to name a few are putting digitalisation high on the agenda. Digitalisation in form of Shared Investigator Platform, eSource, Digital Data Flow, Technology Enabled Common Protocol Template and Blockchain are seen as major initiatives pulling in big pharma, academic institutions and regulators to jointly transform the way we work – and ultimately change pharma’s role in the broader healthcare perspective.

In order to succeed in digitalization, pharma companies are posed with the following questions:

  • What are the skills that are needed to succeed with digitalisation?

  • How do you create an innovative way of thinking in a highly regulated environment?

  • What are the main priorities that produce the desired ROI, while shortening of the development process?

  • What is hype and what is real in the world of digital?

  • How does a digitalisation / eSource approach to data collection affect both sites and trial participants?

  • What changes can we expect to emerge from healthcare digitalization that will impact clinical research?

Martin Holm-Petersen, CEO at Insife and Jesper Kjær, Manager, R&D IT at Novo Nordisk A/S, scientific board of the event, will lead a panel of experts to share best practices, knowledge and experience in this field.

Who should attend?

Representatives of Pharmaceutical and Biotechnology companies, Clinical Research Organizations, Academic centers, Hospital Centers, and Clinical Technology companies. Especially Clinical Research Professionals, belonging to the following departments:

• Clinical Research and Development
• Quality Assurance
• Regulatory
• Pharmacovigilance
• Clinical Operations
• Statistics and Data Management
• Information Technology
• Market Access

Please click here to read the code of good conduct

A portion of the proceeds from this event are donated to the “Vase of Flowers” project

Vaso di Fiori

Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more